Skip to main content

22 November 2025

Last updated: Saturday 22 November 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

How Innate Pharma turned a threat into an opportunity

Monday 10 November 2008

Interviewee/Contributor

Herve Brailly

Organisation

Innate Pharma SA

Organisations

Mind Medicine Inc
Avacta Life Sciences
Oxford Biomedica Plc
BC Platforms AG
SciTribe and BioBeat
4-Antibody AG
Marks and Clerk LLP
Eli Lilly and Company
Truffle Capital
Evotec SE

Interviewees and Contributers

Christian Grøndahl
Marie Manley and Zina Chatzidimitriadou
Shiva Memari
Catherine Pickering
Graeme Martin
Kai Uwe Bindseil
Peter Charlish
Cornelis Melief
Louise Modis
Oliver Rausch

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Werner Lanthaler appointed CEO of FairJourney Biologics

Thursday 6 November 2025

New CEO at Evaxion

Thursday 6 November 2025

Draig Therapeutics appoints President and CEO

Thursday 6 November 2025

Forbion appoints partner in growth fund

Thursday 6 November 2025

Amphista Therapeutics names executives to drive clinical development

Thursday 6 November 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form